The dinosaur named Llukalkan aliocranianus was a predator with a menacing appearance and the ability to strike fear in its prey. Paleontologists said it roamed the Earth nearly 80 million years ago.
One of the hottest areas of research right now: studies to determine how well current vaccines work against emerging coronavirus "variants of concern."
NOAA is updating its definition of what a "normal" Atlantic hurricane season looks like, based on the last 30 years. The average number of hurricanes in the new normal has risen from 6 to 7.
An ear made from an apple, a spinal cord rebuilt using asparagus...it sounds like bizarre science fiction. But Andrew Pelling is working on a way to revive human tissue with a trip to the supermarket.
A group of paleontologists in Patagonia, Argentina, discovered a new dinosaur species resembling a T-rex that "causes fear."
Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.
In May, NOAA will release its once-a-decade update for the 30-year weather averages that local meteorologists use. In many places, it will mean far fewer days that are "above normal."
The three vaccines available in the U.S. are safe and effective, but not ideal. Now, work is underway to create more convenient and potent vaccines, including a tablet and nasal spray.
Greenlanders are going to the polls Tuesday in a crucial election that could determine if the island taps its vast deposits of rare-earth minerals to fuel eventual independence from Denmark.
A medical team in New York City says it has performed the first complete surgical transplant of a trachea. These kinds of transplants are one of the last big transplant challenges.
A new book delves into humanity's long march to overcoming distrust.
White evangelical Christians are one of the most vaccine-hesitant groups in the United States. They're also among the largest religious groups, and their reluctance poses a public health challenge.
The successful deployment of Ingenuity brings NASA one step closer to its first attempt at testing the possibility of powered, controlled flight on another planet.
The site was producing substances for both the Johnson & Johnson and AstraZeneca vaccines. But following a mix-up, the facility will focus solely on producing ingredients for the J&J vaccine.
At an animal sanctuary in the Congo, young students are learning why the gentle, endangered apes known as bonobos should be seen as a national treasure.